SCHIZOPHRENIA FOR A LEVEL

Written By Rebecca Sylvia

CONTENTS/SPECIFICATION

  • CLASSIFICATION OF SCHIZOPHRENIA:
    Positive symptoms of schizophrenia include hallucinations and delusions. Negative symptoms of schizophrenia include speech poverty and avolition.

  • RELIABILITY AND VALIDITY IN DIAGNOSIS AND CLASSIFICATION OF SCHIZOPHRENIA:
    Including references to comorbidity, culture and gender bias, and symptom overlap.

  • BIOLOGICAL EXPLANATIONS FOR SCHIZOPHRENIA:
    Genetics and neural correlates, including the dopamine hypothesis.

  • PSYCHOLOGICAL EXPLANATIONS FOR SCHIZOPHRENIA:
    Family dysfunction and cognitive explanations, including dysfunctional thought processing.

  • DRUG THERAPY":
    Typical and atypical antipsychotics.

  • COGNITIVE BEHAVIOUR THERAPY AND FAMILY THERAPY:
    As used in the treatment of schizophrenia. Token economies are used in the management of schizophrenia.

  • THE IMPORTANCE OF AN INTERACTIONIST APPROACH:
    In explaining and treating schizophrenia: the diathesis stress model.

SUPPORT PSYCHSTORY

〰️

SUPPORT PSYCHSTORY 〰️

CLASSIFICATION OF SCHIZOPHRENIA

Classification of schizophrenia refers to describing what the disorder is like, by identifying the characteristic patterns of symptoms that define schizophrenia as a mental disorder

WHAT IS SCHIZOPHRENIA

  • Positive symptoms of schizophrenia include hallucinations and delusions.

  • Negative symptoms of schizophrenia include speech poverty and avolition.

Schizophrenia is a severe mental disorder characterised by disturbances in perception, thought, emotion, and the sense of self. It involves a breakdown in the way experiences are organised, prioritised, and given meaning. The disorder varies widely in its presentation and course, which is why schizophrenia is now understood as a spectrum disorder rather than a single, uniform condition.

Symptoms are commonly classified as positive or negative.

Positive symptoms are particularly associated with disturbances of thought and language that tend to appear in the early and more acute phases of schizophrenia. These symptoms are the most visible and clinically striking and have historically shaped how the disorder has been described. Speech disturbances such as derailment, word salad, clang associations, and neologisms all fall within this positive symptom cluster. However, they do not represent the whole disorder and do not account for negative symptoms, which form a separate and often more enduring part of schizophrenia.

Positive symptoms are behaviours or experiences that are in excess and are not typically present in healthy psychological functioning. A central feature underlying many positive symptoms is a breakdown in perceptual and cognitive filtering. In everyday life, people are exposed to vast amounts of sensory and cognitive information, yet they can automatically filter out irrelevant information. This selective attention allows perception, thought, and behaviour to remain coherent. A person can read a sentence while ignoring background noise or follow a conversation without being distracted by unrelated details. The mind continuously sorts, prioritises, and assigns importance to information without conscious effort.

Individuals with schizophrenia cannot rely on this filtering system. Incoming sensations, memories, thoughts, associations, and background stimuli all compete at the same level. Nothing is reliably ranked as more or less important, and irrelevant information is not automatically dismissed. The result is an overload of impressions that cannot be integrated into a stable and meaningful whole. Attention shifts rapidly, not because the individual chooses to, but because everything appears equally significant.

This breakdown in filtering is expressed clearly in thought and language. A simple sentence such as “I went outside to get some bread” may fail to remain a single coherent idea. Instead, individual words may trigger uncontrolled chains of association. For example, “bread” may evoke thoughts of buns, which may then evoke thoughts of guns, as associations can be driven by meaning or by sound rather than by relevance. The individual is often unable to explain why their thoughts have moved in this way. When thoughts appear suddenly and without an obvious cause, they may feel intrusive or unfamiliar, which can contribute to confusion, suspiciousness, or paranoia.

Most people experience their inner speech as clearly their own. In schizophrenia, this boundary becomes unreliable because individuals cannot understand why certain thoughts feel important or why they have appeared at all. As a result, internal thoughts may be experienced as coming from outside the self or being imposed by an external force. This contributes to experiences such as thought insertion, thought withdrawal, and thought broadcasting. The usual integration between thought, emotion, and behaviour breaks down. What a person thinks, feels, and does no longer aligns smoothly. The self loses its role as the organising centre of experience, and individuals may feel detached from their own mind or body.

This disruption to filtering and meaning assignment leads directly to other positive symptoms. Hallucinations, most commonly auditory, occur when internally generated thoughts or perceptions are misinterpreted as external and experienced as real. Delusions arise when excessive significance is assigned to neutral or unrelated events, resulting in fixed false beliefs that persist despite contradictory evidence. Disorganised thinking is reflected in speech patterns such as derailment, incoherence or “word salad”, neologisms, and clang associations, where speech is guided by sound rather than meaning. These disturbances are most prominent during acute phases of schizophrenia and are often the most noticeable clinically.

Negative symptoms involve a reduction or loss of normal psychological functioning and tend to be more persistent over time. These include avolition, a lack of motivation or goal-directed behaviour; alogia, reduced speech output; anhedonia, a diminished ability to experience pleasure; and flattened affect, where emotional expression is reduced or absent. Individuals may withdraw socially, appear emotionally detached, and show little spontaneous movement or engagement with their environment. Negative symptoms are strongly associated with poor long-term functioning and are often more resistant to treatment than positive symptoms.

In addition to positive and negative symptoms, schizophrenia frequently involves disturbances in the individual’s sense of self and their relationship with reality. The boundary between internal mental events and external experiences may become blurred, leading to a loss of agency over thoughts and actions. Behaviour may appear disorganised or inappropriate because perception, thought, and action are no longer effectively integrated. Mood disturbances are also common, including anxiety, depression, and emotional blunting.

The course of schizophrenia varies considerably. Some individuals experience a gradual onset, with subtle changes and early negative symptoms dominating the clinical picture, while others develop sudden and severe positive symptoms. Periods of acute psychosis may be followed by partial recovery, although many individuals experience ongoing difficulties. Because of this variability in symptom patterns and progression, schizophrenia cannot be understood as a single illness with a single cause, but as a complex disorder with multiple interacting features

DEAR STUDENTS ,

AQA requires you to formally know very little about the classification of schizophrenia, e.g., what schizophrenia actually is.

The specification says you must know:

  • Positive symptoms of schizophrenia, including hallucinations and delusions.

  • Negative symptoms of schizophrenia, including speech poverty and avolition.

And that’s it, which is surprising given the complexity of schizophrenia. It is one of the more difficult illnesses to understand. The truth is, AQA are never really going to ask you what schizophrenia is in the examination.

At most, they occasionally ask a five-mark question, such as

“Outline the classification of schizophrenia”

And when they do, the examiner is looking for similar descriptions as outlined in the AQA specification, for example: Positive symptoms of schizophrenia include hallucinations and delusions. Negative symptoms of schizophrenia include speech poverty and avolition.

MODEL ANSWER:

Schizophrenia (SZ) is a complex and heterogeneous mental disorder, making it difficult to classify. Individuals diagnosed with schizophrenia can present with very different patterns of symptoms. The disorder is characterised by disturbances in thought processes that are often disorganised or fragmented, and these disturbances are reflected in speech and behaviour. A key feature is a loss of contact with reality, alongside disturbances in both the form and content of thought.

Schizophrenia also affects mood and an individual’s sense of self in relation to the external world. Behaviour may appear purposeless or inappropriate, and individuals may experience distortions of reality, social withdrawal, and impaired functioning. In some cases, schizophrenia develops gradually, with early symptoms dominated by negative features such as reduced emotional expression, poverty of speech, and a lack of motivation or self-initiated behaviour. In other cases, the disorder is characterised by prominent positive symptoms, including auditory hallucinations, paranoid delusions, and disorganised or excessive behaviour.

Due to this wide variation in symptom profiles, schizophrenia is now understood and classified as a spectrum disorder rather than a single, uniform condition

You may also see multiple-choice or short-answer questions on the difference between positive and negative symptoms. But that is it. HONESTLY! Yet , despite being told this, students are often tempted to tell the examiner what schizophrenia is when asked, for example,

“Outline and evaluate biological explanations for schizophrenia”.

They produce a half-paragraph (or more) describing the disorder before finally getting to the biological explanation. In those cases, everything they wrote that “describes” what schizophrenia is earns no credit at all. This is because the question did not ask you what schizophrenia is. It asked you to “describe” two biological explanations (theories ) of schizophrenia. Therefore, the essay should have started like this:

“One biological explanation/theory of schizophrenia is the dopamine hypothesis/genetic theory …”

This naturally raises the question of why we bother studying the disorder in such depth. The short answer is that without a proper grasp of schizophrenia, the explanations make no sense. You cannot meaningfully understand the dopamine hypothesis if you have no firm idea of the symptoms dopamine is supposed to be influencing. The same applies to validity and reliability. How can anyone evaluate whether schizophrenia is a “valid” or “reliable” construct — whether it is, in effect, a social construction — if they are unclear on what the symptoms look like, how they present, or how effectively they respond to treatment?

That is why this section is so substantial, even though the specification itself appears to ask for very little. If you do not understand the disorder, you cannot understand the explanations. If you do not understand the explanations, you cannot evaluate them. And if you cannot assess them, you cannot secure high marks. In other words, the foundation is non-negotiable.

CLASSIFICATION OF SCHIZOPHRENIA QUESTIONS

POSITIVE / NEGATIVE SYMPTOM CLASSIFICATION ASSESSMENT

SHORT QUESTIONS

  1.  Which of the following are not negative symptoms: ( 1 mark for each correct answer)

    Hallucinations

    Avolition

    Delusions

    Anhedonia

    Poverty of speech

    Thought control

  2. Give two examples of how language can be disordered in Schizophrenia. (4 marks)

  3. What is a delusion? (3 marks)

  4.  What is a hallucination? (3 marks)

  5. Outline two positive symptoms (4 marks)

  6. Define positive symptoms (4 marks)

  7.  Define negative symptoms (4 marks)

  8.  Outline four negative symptoms. (8 marks)

  9.  What is meant by affect? (2 marks)

  10. Name four different types of affect (4 marks)

  11. Name and briefly outline one negative symptom of schizophrenia. (2 marks)

  12. Using your knowledge of schizophrenia, explain why Louise is now showing symptoms of schizophrenia. (4 marks)

    Read the item and then answer the question above:
    Louise comes from a family with a history of schizophrenia, as both her grandfather and an aunt have been diagnosed with the disorder. Louise’s father has recently died from cancer, and she has just moved out of the family home to start a university course. Although she has always been healthy in the past, she has just begun to experience symptoms of schizophrenia, such as delusions and hallucinations.

  13.  What is the difference between chronic and acute onset Schizophrenia? (4 marks)

  14.  What is Type One Schizophrenia? (4 marks)

  15.  Why is using the Type One Schizophrenia and Type Two Schizophrenia categorisations of schizophrenia fallible? (4 marks)

  16.  How long do symptoms have to be present before a diagnosis of Schizophrenia can be made for ICD-11 and DSM-5? (1 mark)

  17. Name ICD subtypes (7 marks)

  18. Name the DSM IV subtypes (5 marks)

  19. Name two differences between the current ICD-11 and DSM-5 in Schizophrenia classification? 4 marks)

  20. Outline the classification of Schizophrenia (6 marks)

  21. Circle the relevant words or phrases in the examples below and identify the pathology shown.

    State clearly whether the presentation indicates:

  • POSITIVE SYMPTOMS
    If so, specify which: loose associations, knight’s move thinking, clang associations, neologisms, word salad, thought disorder, hallucinations, delusions (give exact examples from the text).

  • NEGATIVE SYMPTOMS
    If so, specify which: disturbances of motivation (avolition, apathy, anhedonia, social withdrawal) or disturbances of affect (flat affect, blunted affect, inappropriate/incongruent affect). Give exact examples

EXAMPLE ONE

  • I am a nun. If that’s not enough, you are still his. That is a brave cavalier; take him as your boon-swagger, Caroline; you know well you are my lord because I am bored, and you like a sword in the Fjord. If you are the habbicontin, Mrs K is still best by fear. Handle the gravy carefully. Where is my paintbrush? Where are you, Monet?

EXAMPLE TWO

  • “I am writing on paper. The pen which I am using is from a factory called ‘Perry & Co’. This factory is in England. I assume this. Behind the name of Perry Co., the city of London is inscribed, but not the city. The city of London is in England. I know this from my school days. Then, I always liked geography. My last teacher in that subject was Professor August A. He was a man with black eyes. I also like black eyes. There are also blue and grey eyes and other sorts, too. I have heard it said that snakes have green eyes. All people have eyes. There are some, too, who are blind. A boy leads about these blind people. It must be very terrible not to be able to see. There are people who can’t see and, in addition, can’t hear. I know some who hear too much. One can hear too much. There are many sick people in Burgholzi; they are called patients. One of them I like a great deal. His name is E. Sch. He taught me that in Burgholzi, there are many kinds of patients, inmates, and attendants. Then there are some who are not here at all. They are all peculiar people….”

EXAMPLE THREE

  • Carl was twenty-seven years old when he was first admitted to a psychiatric facility. Gangling and intensely shy, he was so incommunicative at the outset that his family had to supply initial information about him. They, it seemed, had been unhappy and uncomfortable with him for quite some time. His father dated the trouble to “sometime in high school.” He reported, “Carl turned inward, spent a lot of time alone, had no friends and did no schoolwork.” His mother was especially troubled about his untidiness. “He was really an embarrassment to us then, and things haven’t improved since. You could never take him anywhere without an argument about washing up. And once he was there, he wouldn’t say anything to anyone.” His twin sisters, six years younger than Carl, said very little during the family interview, instead passively agreeing with their parents.

    One would hardly have guessed from their report that Carl graduated from high school in the upper quarter of his class and went on to college, where he studied engineering for 3 years. Though he had always been shy, he had had one close friend, John Winters, throughout high school and college. John had been killed in a car accident a year earlier. (Asked about Winters, his father said, “Oh, him. We don’t consider him much of anything at all. He didn’t go to church either. And he didn’t do any schoolwork.”)

    Carl and John were unusually close. They went through high school together, served in the army at the same time, and, upon discharge, began college together and roomed in the same house. Both left college before graduating, much to the chagrin of Carl’s parents, took jobs as machinists in the same firm, and moved into a nearby apartment.

    They lived together for three years until John was killed. Two months later, the company for which they worked went out of business. John’s death left Carl enormously distraught. When the company closed, he found himself without the energy and motivation to look for a job. He moved back home. Disagreements between Carl and his family became more frequent and intense. He became more reclusive, sloppy, and bizarre; they became more irritable and isolating. Finally, they could bear his behaviour no longer and took him to the hospital. He went without any resistance.

    After ten days in the hospital, Carl told the psychologist who was working with him, “I am an unreal person. I am made of stone, or else I am made of glass. I am not wrong, precisely. But you will not find my key. I have tried to lose it. You can look at me closely if you wish, but you see more from far away.”

    Shortly thereafter, the psychologist noted that Carl “…smiles when he is uncomfortable, and smiles more when in pain. He cries during television comedies. He seems angry when justice is done, frightened when someone compliments him, and roars with laughter on reading that a young child was burned in a tragic fire. He grimaces often. He eats very little but always carries food away.”

    After two weeks, the psychologist said to him, “You hide a lot. As you say, you are wired precisely wrong. But why won’t you let me see the diagram?”

    Carl answered: “Never, ever will you find the lever, the eternal lever that will sever me forever with my real, seal, deal, heel. It is not on my shoe, not even on my sole. It walks away.

EXAMPLE FOUR: MARY

  • Mary is 21 and was first presented to psychiatric services as an outpatient at the age of 19. She gave a two-month history of social withdrawal associated with paranoid delusions. A diagnosis of probable paranoid schizophrenia was made, and she was treated. However, her condition continued to deteriorate. Over the next two months, she became retarded and mute and was admitted to the hospital. At this time, she began having episodes of freezing and started walking backwards. During her freezing episodes, she would stand rigid for hours and ignore any instructions from nurses to move.

EXAMPLE FIVE TOMMY

  • According to his family, he has always been withdrawn, and his behaviour is sometimes inappropriate. His sister-in-law gave the example of him waking her up in the middle of the night to cook him breakfast. Over the last year, Tommy has frequently talked at length and struggled to understand. He often goes days without speaking to people.

EXAMPLE FIVE DAVE

  • Over the last three months, he has had visions of aliens walking around him at work. His speech has become rambling, and often his friends cannot tell what he is saying. A few weeks ago, Dave was told his old college friend had died, and in response, he laughed. He has stopped showering regularly and believes his water system has been poisoned. He has lost a lot of weight as he no longer bothers to cook. His neighbour was worried about Dave when she saw him sitting on the floor in the corner shop, grimacing.

EXAMPLE SIX: MIKE

  • Mike says he knows someone has removed his brain and replaced it with someone else's. He believes that this brain is controlling him and that he is not responsible for his actions. He works daily and has been in his current job for 15 years. He says he has many friends, but sometimes he thinks one of them did this to him. He is convinced he must protect his brain by wearing a hat (even to bed). He can speak fine and goes to work every day. He doesn’t think his thoughts are unusual.

EXAMPLE SEVEN” SUSAN

  • Susan is 20 years old. She suffered from depression when she was 15. She has now been discharged from her psychiatrist and has been free of depression for the last three years. She is taking her final university exams, has had trouble sleeping, and has had bad dreams over the past few weeks. She is feeling stressed out and overwhelmed

NEURAL CORRELATES AND DOPAMINE HYPOTHESES

NEURAL CORRELATES AND SCHIZOPHRENIA

A neural correlate is a measurable feature of the brain that is associated with a particular behaviour or mental state. Neural correlates can involve differences in:

• brain structure, such as the size or shape of specific brain areas
• brain activity, such as increased or decreased activity in neural pathways
• brain chemistry, such as levels of neurotransmitters like dopamine

These differences may arise due to genetic factors, illness, or environmental experiences.

For example, individuals who lose the ability to produce speech often show damage to Broca’s area in the left frontal lobe. When the same brain area is repeatedly linked to the same functional loss across different individuals, this suggests a close relationship between that brain region and the behaviour.

In clinical psychology, neural correlates are used to link brain features to mental disorders. If a group of individuals with the same disorder also share the same brain abnormality, that abnormality is described as a neural correlate of the disorder.

It is important to note that the term "correlate" does not automatically establish cause and effect. However, when consistent brain differences are repeatedly observed alongside specific behavioural changes, it becomes reasonable to suggest a causal link.

NEURAL CORRELATES IN SCHIZOPHRENIA

A neural correlate of schizophrenia is any consistent physical or functional difference in the brains of people with schizophrenia compared with people without the disorder.

Examples include:

• differences in brain chemistry, particularly dopamine systems
• differences in brain structure, such as enlarged ventricles

Because this is a very broad area, the AQA specification uses the dopamine hypothesis as its key example of a neural correlate of schizophrenia.

CHEMICAL THEORIES OF SCHIZOPHRENIA

Chemical theories explain psychological disorders in terms of neurotransmitter imbalance, meaning abnormally high or abnormally low levels of specific neurotransmitters. Examples already familiar from Year 1 include depression, which is associated with low serotonin, and obsessive-compulsive disorder, which is associated with high dopamine and low serotonin.

Schizophrenia fits this same chemical model. It is partly explained by abnormal dopamine functioning, which affects how the brain processes information and assigns meaning to experiences. This forms the chemical explanation of schizophrenia.

THE ORIGINAL DOPAMINE HYPOTHESIS

The dopamine hypothesis was discovered accidentally in the early 1950s. Antihistamines were given to psychotic patients to reduce surgical shock during operations. During trials on mentally ill patients, it was observed that these drugs reduced hallucinations and delusions in individuals with schizophrenia.

This discovery led to the development of the first generation of antipsychotic drugs, also known as typical antipsychotics.

At the time, it was not known how these drugs worked. In the 1950s, very little was understood about neurotransmitters, and it was commonly believed that neural communication was primarily electrical rather than chemical.

Over the following decades, several sources of evidence began to point towards dopamine:

• Parkinson’s disease patients, who have low dopamine levels, often show symptoms opposite to those of schizophrenia
• Amphetamine addicts, who have increased dopamine availability, often show psychotic symptoms similar to schizophrenia
• Antipsychotic drugs were found to reduce dopamine activity and reduce hallucinations and delusions

This evidence was later supported by post-mortem studies of people with schizophrenia and animal studies using rats.

The original dopamine hypothesis, therefore, proposed that schizophrenia was caused by hyperdopaminergic activity and that excess dopamine produced hallucinations and delusions.

LIMITATIONS OF THE ORIGINAL DOPAMINE HYPOTHESIS

Over time, the original dopamine hypothesis proved incomplete. Most importantly, it failed to account for negative symptoms.

Negative symptoms had initially been assumed to be a byproduct of positive symptoms. However, it became clear that antipsychotic drugs were not effective in treating negative symptoms such as flat affect, anhedonia, and poverty of speech. These symptoms appeared to form a separate and enduring category rather than being secondary effects.

As a result, the dopamine hypothesis was reformulated in the 1990s, alongside improvements in brain imaging technology and neuroscience research.

THE REVISED DOPAMINE HYPOTHESIS

The revised dopamine hypothesis recognises that dopamine does not act in a single, uniform system. Instead, dopamine operates through distinct neural pathways, each with different functions.

The revised hypothesis proposes that schizophrenia involves different patterns of dopamine dysfunction in different pathways, rather than a single overall imbalance

MAJOR DOPAMINE PATHWAYS

Dopamine does not act uniformly throughout the brain. Instead, it operates through several distinct neural pathways. Each pathway begins in a different brain area, projects to a different destination, and has a different function.

The four main dopamine pathways are:

• Nigrostriatal pathway – involved in the control of voluntary movement
• Mesolimbic pathway – involved in reward, motivation, and the assignment of salience, meaning deciding what is important
• Mesocortical pathway – involved in higher-level cognitive functions such as planning, decision-making, and motivation
• Tuberoinfundibular pathway – involved in hormone regulation, particularly the control of prolactin release

The original dopamine hypothesis did not distinguish between these pathways. It treated dopamine as a single system acting in the same way throughout the brain. The revised dopamine hypothesis recognises that different dopamine pathways can be affected in different ways.

DOPAMINE PATHWAYS IMPLICATED IN SCHIZOPHRENIA

The revised dopamine hypothesis proposes that schizophrenia involves dysfunction in two specific dopamine pathways, rather than a general dopamine imbalance.

These are the mesolimbic and mesocortical pathways.

MESOLIMBIC PATHWAY AND POSITIVE SYMPTOMS

In schizophrenia, dopamine activity in the mesolimbic pathway is hyperdopaminergic, meaning dopamine transmission is excessively high.

The mesolimbic pathway plays a key role in salience, the brain’s ability to determine what information is important and should be attended to. When dopamine signalling in this pathway is excessive, the salience system becomes overactive.

As a result, neutral or irrelevant stimuli may be experienced as meaningful, significant, or threatening. Ordinary thoughts, sensations, or external events may stand out excessively and demand attention. This inappropriate assignment of importance leads directly to positive symptoms such as hallucinations and delusions.

MESOCORTICAL PATHWAY AND NEGATIVE SYMPTOMS

In contrast, dopamine activity in the mesocortical pathway is hypodopaminergic, meaning dopamine transmission is reduced.

The mesocortical pathway projects to the prefrontal cortex, an area involved in motivation, planning, working memory, and decision making. When dopamine activity in this pathway is reduced, these cognitive and motivational processes become underactive.

This produces negative symptoms such as avolition, flat affect, and poverty of speech, as well as cognitive impairments, including reduced concentration and poor decision-making.

DOPAMINE RECEPTORS: WHY THERE ARE FIVE

Dopamine does not act on neurons in a single way. Instead, it binds to specialised docking sites called receptors. These receptors differ in structure and function, meaning the same dopamine signal can have different effects depending on which receptor it activates.

There are five dopamine receptors, named in the order they were discovered: D1, D2, D3, D4, and D5.

There are not five different types of dopamine. Rather, there are five different ways the brain responds to dopamine.

DOPAMINE RECEPTOR FAMILIES

Dopamine receptors are grouped into two families based on their effects at the cellular level:

• D1-like receptors (D1 and D5) – generally excitatory, meaning they increase neuronal activity
• D2-like receptors (D2, D3, and D4) – generally inhibitory, meaning they reduce neuronal activity

These cellular effects vary depending on the neural pathway involved.

For schizophrenia, the most important receptors are D1 and D2.

RECEPTORS, PATHWAYS, AND SYMPTOMS

Mesolimbic pathway
In schizophrenia, excessive dopamine stimulation of D2 receptors occurs in the mesolimbic pathway. Although D2 receptors are inhibitory at the level of individual neurons, excessive stimulation can make the overall pathway overactive. This disrupts salience processing and leads to positive symptoms such as hallucinations and delusions.

Mesocortical pathway
In schizophrenia, reduced dopamine stimulation of D1 receptors occurs in the mesocortical pathway. Although D1 receptors are excitatory, insufficient dopamine input can make the overall pathway underactive. This results in negative symptoms and cognitive deficits such as reduced motivation, poverty of speech, and impaired thinking.

SUMMARY FOR STUDENTS

• Hyperdopaminergic activity in the mesolimbic pathway, acting mainly via D2 receptors, is associated with positive symptoms
• Hypodopaminergic activity in the mesocortical pathway, acting mainly via D1 receptors, is associated with negative and cognitive symptoms

This explains why schizophrenia cannot be explained by a single dopamine imbalance and supports the revised dopamine hypothesis as a neural correlate of the disorder

SUPPORTING EVIDENCE

SUPPORTING EVIDENCE FOR THE DOPAMINE HYPOTHESIS (CHRONOLOGICAL)

1952 – Delay and Deniker
Chlorpromazine was given to psychiatric patients to reduce surgical shock and agitation. It was accidentally discovered that the drug reduced hallucinations and delusions in patients with schizophrenia. This led to the development of the first generation of antipsychotics, known as typical antipsychotics. At the time, the mechanism of action was unknown, but the clinical effect on positive symptoms suggested a biological basis to schizophrenia. This discovery provided the first indirect support for a chemical explanation of schizophrenia.

1963 – Carlsson and Lindqvist
Carlsson and Lindqvist proposed that antipsychotic drugs reduce dopamine activity in the brain. They showed that chlorpromazine and similar drugs blocked dopamine receptors rather than simply sedating patients. This was a major turning point because it linked symptom reduction directly to dopamine function. Their work provided the first theoretical foundation for the original dopamine hypothesis, suggesting that schizophrenia involved abnormal dopamine activity.

1960s–1970s – Parkinson’s disease evidence
Parkinson’s disease patients were found to have low dopamine levels and showed motor symptoms such as tremors and rigidity. When treated with L-DOPA, which increases dopamine availability, some patients developed hallucinations and delusions similar to those seen in schizophrenia. This supported the idea that increased dopamine activity can produce psychotic symptoms, strengthening the link between dopamine and positive symptoms of schizophrenia.

1970s – Amphetamine studies and drug addicts
Amphetamines increase dopamine availability in the brain. Studies found that amphetamine use could induce psychosis in non-schizophrenic individuals and worsen symptoms in those already diagnosed. This provided strong support for the dopamine hypothesis, as artificially increasing dopamine led to schizophrenia-like symptoms, particularly hallucinations and delusions.

1976 – Seeman et al.
Seeman and colleagues demonstrated that the effectiveness of antipsychotic drugs was strongly correlated with their ability to block D2 dopamine receptors. Drugs with higher D2 receptor affinity were more effective at reducing positive symptoms. This was important evidence because it showed a consistent relationship between dopamine receptor blockade and symptom reduction, strengthening the validity of dopamine-based explanations.

1980s – Post-mortem studies
Post-mortem examinations of schizophrenic brains revealed increased dopamine receptor density, particularly D2 receptors, in some patients. This suggested long-term alterations in dopamine systems. However, a limitation is that many patients had taken antipsychotic medication, which itself increases receptor density. This weakens causal conclusions but still supports the involvement of dopamine as a neural correlate.

1980s–1990s – Animal studies (rats)
Animal research showed that increasing dopamine activity in rats produced behaviours similar to psychosis, while dopamine blockade reduced these behaviours. These controlled experiments strengthened causal claims by showing that manipulating dopamine levels directly affected behaviour. However, generalisation to humans is limited.

1990s – Brain imaging (PET and fMRI)
Advances in brain imaging allowed dopamine activity to be studied in living patients. PET scans showed increased dopamine synthesis and release in the striatum of individuals with schizophrenia. These findings supported the revised dopamine hypothesis by showing pathway-specific dysfunction rather than a global dopamine excess.

2000 – Howes and Kapur
Howes and Kapur reformulated the dopamine hypothesis as a disorder of salience. They proposed that excessive dopamine activity in the mesolimbic pathway leads to inappropriate assignment of importance to irrelevant stimuli. This explains hallucinations and delusions as attempts to make sense of abnormal salience. This version has greater explanatory power and aligns better with both the symptom presentation and the imaging evidence.

Evaluation and AO3 conclusion
Overall, evidence from antipsychotics, drug studies, neurological disorders, post-mortem research, animal studies, and brain imaging consistently links dopamine dysfunction to schizophrenia, particularly positive symptoms. However, the original dopamine hypothesis was incomplete because it could not explain negative symptoms. This limitation led to the revised dopamine hypothesis, which recognises different patterns of dopamine dysfunction across different neural pathways. While dopamine dysfunction is strongly implicated, it is best understood as a neural correlate rather than a sole cause of schizophrenia.

EVALUATION OF THE DOPAMINE HYPOTHESES (AO3)

SUPPORT FROM ATYPICAL ANTIPSYCHOTICS (LIMITED SUPPORT)
The development of atypical antipsychotics in the 1990s initially appeared to support the reformulated dopamine hypothesis. Unlike typical antipsychotics, early atypicals such as risperidone block both dopamine D2 receptors and serotonin 5-HT₂A receptors. This dual action was important because it suggested that schizophrenia could not be explained by dopamine alone.
Blocking D2 receptors in the mesolimbic pathway reduces hallucinations and delusions, supporting the idea that positive symptoms are linked to dopamine dysregulation. At the same time, blocking 5-HT₂A receptors reduces serotonin-mediated inhibition of dopamine release in the prefrontal cortex, allowing dopamine transmission in the mesocortical pathway to recover. This explains why early atypicals showed some improvement in negative and cognitive symptoms compared to first-generation drugs.
However, this support is partial and limited. Atypical antipsychotics are better tolerated and show modest benefits for negative symptoms, but they do not reliably reverse core motivational or cognitive deficits. This weakens the claim that a dopamine imbalance, even when pathway-specific, is sufficient to account for the full disorder.

DELAYED THERAPEUTIC RESPONSE
A major problem for all dopamine-based explanations is the delay between dopamine blockade and symptom improvement. D2 receptors are blocked within hours of taking antipsychotic medication, yet clinical improvement typically takes several weeks.
If schizophrenia symptoms were the direct and immediate result of excess dopamine activity, improvement would be expected to occur rapidly. The delay suggests that dopamine dysregulation may initiate psychosis, but symptom persistence depends on secondary neural changes, such as altered gene expression, synaptic plasticity, and interactions with other neurotransmitter systems.
This weakens a simple causal interpretation of dopamine imbalance.

STRUCTURAL NEURAL CORRELATES BEYOND DOPAMINE
Neuroimaging and post-mortem studies identify consistent structural abnormalities in schizophrenia that are not explained by dopamine alone. One of the most robust findings is enlarged cerebral ventricles, reflecting reduced surrounding brain tissue.
Patients with greater ventricular enlargement tend to show more severe negative symptoms and cognitive impairment, whereas those with relatively normal ventricular size are more likely to show predominantly positive symptoms. This suggests that different symptom profiles may be associated with different underlying neural abnormalities.
Although long-term antipsychotic use may contribute to ventricular enlargement, these findings indicate that schizophrenia involves broader brain changes beyond neurotransmitter imbalance.

PREFRONTAL CORTEX HYPOFUNCTION
Functional imaging studies consistently show hypofrontality in schizophrenia, particularly in the dorsolateral prefrontal cortex. Reduced activity in this region is associated with impaired planning, attention, and motivation, as well as disorganised thought.
This pattern aligns with negative and cognitive symptoms but cannot be fully explained by dopamine dysfunction alone. Reduced grey matter volume, disrupted connectivity, and GABAergic dysfunction are also implicated, suggesting a disorder of distributed neural networks rather than a single neurotransmitter fault.

BEYOND DOPAMINE: GLUTAMATE AS AN UPSTREAM PROBLEM

Noll (2009) pointed out that approximately one-third of patients with schizophrenia do not improve when treated with dopamine-blocking antipsychotic drugs, indicating that other neurotransmitters are likely involved in the disorder.
The dopamine hypothesis does not explain why dopamine systems become dysregulated. Evidence increasingly points to hypofunction of the NMDA-type glutamate receptor as an upstream abnormality that disrupts dopamine regulation.
NMDA receptor dysfunction can simultaneously produce excessive dopamine activity in mesolimbic pathways and reduced dopamine activity in mesocortical pathways, accounting for both positive and negative symptoms. This explains why dopamine-blocking drugs reduce hallucinations but fail to restore motivation or cognition, and why clozapine is effective in treatment-resistant cases.
This places dopamine dysregulation downstream of a more fundamental neural disturbance.

LACK OF DISORDER SPECIFICITY
A further limitation of the dopamine hypothesis is its poor diagnostic specificity. Dopamine dysregulation is not unique to schizophrenia. Similar patterns of dopaminergic disturbance are observed in mania, acute and transient psychotic disorders, schizoaffective disorder, and schizotypal personality disorder. All of these conditions can involve hallucinations, delusions, or thought disturbance, yet they are classified as distinct disorders with different courses and outcomes.
This weakens the claim that dopamine dysregulation causes schizophrenia specifically. Instead, dopamine abnormalities appear to be linked to psychotic symptoms in general, rather than to schizophrenia as a discrete illness. This raises a fundamental question: is dopamine dysfunction the cause of schizophrenia, or simply the neural signature of psychosis itself?

CAUSAL DIRECTION: SYMPTOMS OR DISORDER FIRST
The dopamine hypothesis does not resolve the issue of causal direction. It remains unclear whether dopamine dysregulation causes schizophrenia or whether the emergence of psychotic symptoms leads to secondary changes in dopamine systems. For example, repeated psychotic episodes, chronic stress, or prolonged arousal may themselves sensitise dopamine pathways over time.
This uncertainty weakens strong causal claims and supports the view that dopamine abnormalities may be consequences or maintaining factors, rather than the original cause of the disorder. This issue naturally leads to genetic explanations, which aim to identify pre-symptomatic vulnerabilities.

GENETIC EVIDENCE AND THE LIMITS OF BIOLOGICAL DETERMINISM

A significant challenge to the hypothesis emerged from Farde et al. (1990), who found no differences in dopamine levels (or D2 receptor densities) between individuals with schizophrenia and healthy controls.
Genetic research provides strong evidence for a biological vulnerability to schizophrenia, but also demonstrates that biology alone is insufficient. Concordance rates for monozygotic twins are consistently around 46–48 %, despite identical genetic material. This clearly shows a substantial genetic contribution, but also demonstrates that schizophrenia is not genetically inevitable.
Studies of separated twins are not relied upon due to very small sample sizes, which limit statistical reliability. Therefore, conclusions are based primarily on larger concordance datasets.
Recent genetic research, including findings on the C4 gene, suggests that schizophrenia risk may involve abnormal synaptic pruning during adolescence. However, genetic vulnerability does not determine outcome. Many individuals with high genetic risk never develop schizophrenia, indicating that additional factors are required.

DIATHESIS–STRESS MODEL
The limitations of both dopamine and genetic explanations have led to the dominance of the diathesis–stress model. This model proposes that schizophrenia develops when a biological vulnerability (such as genetic risk, abnormal dopamine or glutamate function, or atypical brain development) interacts with environmental stressors.
Relevant stressors include childhood trauma, family conflict, substance use (particularly cannabis), social adversity, and major life events. Neither vulnerability nor stress alone is sufficient. Schizophrenia emerges only when both are present in combination.
This model integrates biological, psychological, and social factors and explains why concordance in identical twins is well below 100 %, why onset often occurs in late adolescence, and why symptom severity varies widely between individuals.

A final limitation is that the dopamine hypothesis can be viewed as biologically deterministic. Even if someone has elevated dopamine activity, it does not inevitably mean they will develop schizophrenia. This approach overlooks the role of personal agency and free will, implying that biology alone dictates the onset of the condition.

OVERALL AO3 CONCLUSION
Dopamine dysregulation is a robust and well-supported neural correlate of psychosis, particularly positive symptoms, but it lacks disorder specificity and cannot explain why schizophrenia develops in some individuals and not others. Genetic evidence strengthens the biological case, but incomplete concordance rates rule out purely biological determinism. Current thinking, therefore, places schizophrenia within an interactionist framework, where dopamine dysfunction reflects one component of a broader vulnerability that only becomes pathological under certain environmental conditions

THE DOPAMINE HYPOTHESES QUESTIONS

  1. What part of the brain is associated with Positive symptoms of schizophrenia (1 mark)?

  2. What part of the brain is associated with Negative symptoms of schizophrenia (1 mark)?

  3. Which dopamine receptor is associated with positive symptoms of schizophrenia (1 mark)?

  4. Which dopamine receptor is associated with negative symptoms of schizophrenia (1 mark)?

  5. What is a neural correlate? (2 marks).

  6. Why is the dopamine hypothesis a neural correlate (3 marks)?

  7. Give two disadvantages of the original dopamine hypothesis (4 marks)?

  8. What do people typically experience when they have hyperdopaminergic systems (4 marks)?

  9. What do people typically experience when they have hypodopaminergic systems (4 marks)?

  10. What is the original Dopamine 1 hypothesis (3 marks)

  11. What is the reformulated Dopamine hypothesis (3 marks)

  12. Outline the Dopamine hypothesis ( 6 marks).

  13. Describe three disorders where dopamine irregularity appears in conditions or states other than schizophrenia and explain why this challenges the original hypothesis. (3 marks)?

  14. Name three disadvantages of the reformulated Dopamine hypothesis. (6 marks)

  15. Why is the dopamine hypothesis not a complete explanation of schizophrenia (6 marks)?

  16. Antipsychotic medication reduces positive symptoms of schizophrenia but has limited effects on negative and cognitive symptoms. Explain why this pattern is a problem for a purely hyperdopaminergic explanation of schizophrenia.(4 marks)

  17. A researcher gives amphetamines to healthy volunteers in a controlled setting. Some participants report hearing voices and developing paranoid interpretations of neutral events. Using the dopamine hypothesis, explain how amphetamine effects are used as evidence for dopamine involvement in psychosis (6 marks)

  18. Why do symptoms of schizophrenia usually take several weeks to improve after dopamine receptors are blocked, even though blockade occurs almost immediately, and what does this suggest about the limitations of the dopamine hypothesis? ( 4 marks.)?

  19. Early atypical antipsychotics block D2 receptors and also block serotonin 5-HT2A receptors. Some patients show modest improvement in negative symptoms compared with typical antipsychotics. Using the reformulated dopamine hypothesis, explain why serotonin blockade could increase dopamine transmission in mesocortical areas and why this is only limited support (6 marks).

  20. PET imaging finds increased dopamine synthesis capacity in the striatum during acute psychosis, but similar dopamine patterns are found in psychotic bipolar disorder and drug-induced psychosis. Explain why this challenges the claim that dopamine dysregulation causes schizophrenia, specifically 6 marks.

  21. Monozygotic twin concordance for schizophrenia is about 46 to 48 per cent. Explain what this suggests about biological determinism and why it supports an interactionist explanation, such as diathesis stress (6 marks).

  22. Discuss the dopamine hypothesis of schizophrenia (16 marks)

WRITING ESSAYS FOR THE DOPAMINE HYPOTHESIS

Discuss one or more explanations for schizophrenia. Refer to Jay in your answer. (16 marks: AO1 – 6, A02 - 4, AO3 – 6)
WORD COUNT GUIDELINES FOR AQA A-LEVEL PSYCHOLOGY RESPONSES

  • 6-mark A01 response: ~225 words approx.

  • 3-mark A01 response: ~112 words approx.

SIX-MARK A01 RESPONSE (APPROX. 225 WORDS)

The dopamine hypothesis is a neural correlate of schizophrenia, as it identifies dopamine imbalances in specific brain regions as a cause of symptoms. The original dopamine hypothesis suggested that positive symptoms, such as hallucinations and delusions, result from excess dopamine (hyperdopaminergic activity) in the mesolimbic pathway. This pathway connects the ventral tegmental area (VTA) to the nucleus accumbens, a structure involved in reward and motivation. Overactivation of D2 receptors in this system disrupts standard information processing, leading to distorted perceptions and thoughts.

However, this model did not account for negative symptoms, such as apathy and cognitive dysfunction, prompting a reformulation of the dopamine hypothesis. This version proposes that negative symptoms arise due to too little dopamine (hypodopaminergic activity) in the mesocortical pathway. This connects the VTA to the prefrontal cortex, a region responsible for higher-order thinking, planning, and motivation. D1 receptors in the prefrontal cortex are excitatory, meaning they enhance brain activity, but underactivity of dopamine in this pathway reduces prefrontal function, leading to persistent negative symptoms.

Since distinct patterns of dopamine dysfunction correspond to different symptom types, the dopamine hypothesis provides a biological explanation for schizophrenia. It is considered a neural correlate because it links specific brain abnormalities to the development of symptoms, helping to explain why schizophrenia presents with both excessive and diminished mental activity.

THREE-MARK A01 RESPONSE (APPROX. 112 WORDS)

The dopamine hypothesis is a neural correlate of schizophrenia, as it links dopamine dysfunction in specific brain pathways to distinct symptoms. The original dopamine hypothesis suggested that positive symptoms, such as hallucinations and delusions, result from too much dopamine (hyperdopaminergic activity) in the mesolimbic pathway. This system connects the ventral tegmental area (VTA) to the nucleus accumbens, which processes reward and emotion. Overactivation of D2 receptors in this system disrupts thought processing, leading to perceptual distortions.

The reformulated dopamine hypothesis explains negative symptoms, such as apathy, by positing that they result from reduced dopamine (hypodopaminergic) activity in the mesocortical pathway. This pathway links the VTA to the prefrontal cortex, which controls motivation and cognitive function. D1 receptors in this region require sufficient dopamine, and when levels are too low, negative symptoms such as reduced motivation and cognitive impairment emerge

WRITING A03

RESEARCH ANALYSIS: LEGAL DOPAMINE ANTAGONISTS (ANTIPSYCHOTIC MEDICATIONS)

  • STENGTHS

    • The most substantial empirical support for the dopamine hypothesis comes from the success of typical antipsychotic drugs (e.g., chlorpromazine) in reducing positive symptoms of schizophrenia. These drugs block dopamine D2 receptors, reducing dopamine transmission in the mesolimbic pathway.

    • Atypical antipsychotics (e.g., clozapine, risperidone) are also effective, and while they target dopamine, they additionally affect serotonin (5-HT2A receptors), which helps alleviate negative symptoms such as avolition and affective flattening.

    • The effectiveness of these medications directly supports the idea that excess dopamine contributes to psychotic symptoms, as reducing dopamine levels alleviates hallucinations and delusions.

  • WEAKNESSES:

    • While typical antipsychotics support the dopamine hypothesis by reducing positive symptoms, they fail to address negative symptoms like social withdrawal and cognitive dysfunction. This suggests dopamine alone cannot fully explain schizophrenia.

    • Some patients with schizophrenia do not respond to dopamine antagonists, implying other neurotransmitter systems (e.g., glutamate, serotonin) contribute to the disorder.

    • Dopamine dysfunction does not account for all neural correlates of schizophrenia. Brain imaging studies suggest structural abnormalities (e.g., enlarged ventricles, prefrontal cortex dysfunction) are also involved, indicating that schizophrenia is not just a chemical imbalance but a disorder with broader neurobiological underpinnings.

  • Conclusion:

    • The efficacy of dopamine-blocking drugs in treating positive symptoms supports the dopamine hypothesis. Still, their limited effect on negative symptoms and individual differences in response suggest that additional factors contribute to schizophrenia.

    • The fact that atypical antipsychotics also target serotonin and show greater effectiveness in treating negative symptoms highlights the need for a broader neurotransmitter model beyond dopamine alone.

RESEARCH ANALYSIS: ANIMAL STUDIES (RATS)

  • Strengths: Rats share a similar mesolimbic dopamine system with humans, making them valuable for studying the effects of dopamine agonists and antagonists.

  • Weaknesses: Rats lack human-specific cognitive functions, particularly language, which is central to schizophrenia. The inability to directly assess hallucinations or delusions in rats raises validity concerns. Furthermore, schizophrenia may be uniquely human, limiting generalisability.

  • Conclusion: While rat studies provide insight into dopamine pathways, their inability to replicate the whole human experience of schizophrenia weakens their applicability.

RESEARCH ANALYSIS: ANTIPSYCHOTICS & PARKINSON'S DISEASE

  • Strengths: The link between Parkinson’s disease and schizophrenia provides compelling evidence for dopamine’s role. L-DOPA (a dopamine agonist) can induce psychotic symptoms in Parkinson’s patients, mirroring schizophrenia. Conversely, dopamine antagonists used in schizophrenia treatment can cause Parkinsonian symptoms.

  • Weaknesses: The exact mechanisms of schizophrenia differ from those of drug-induced psychosis. Parkinson’s patients do not develop all schizophrenia symptoms, suggesting additional neurochemical or structural abnormalities.

  • Conclusion: The Parkinson-schizophrenia link supports the dopamine hypothesis but does not account for all symptoms or underlying causes.

RESEARCH ANALYSIS: ILLEGAL DRUGS

  • Strengths: Drug-induced psychosis mimics schizophrenia symptoms, supporting the role of dopamine excess in positive symptoms. Studies from the 1970s induced amphetamine psychosis to examine schizophrenia-like behaviours, reinforcing the dopamine hypothesis.

  • Weaknesses: Drug-induced psychosis is now considered qualitatively different from schizophrenia, with additional symptoms like euphoria and hyperactivity resembling mania rather than schizophrenia.

  • Conclusion: While illicit drug studies reinforce dopamine’s role in psychosis, they cannot fully explain schizophrenia’s complexity.

POST-MORTEM STUDIES

  • Strengths: Early post-mortem studies found increased dopamine receptor density, suggesting a biological basis for schizophrenia.

  • Weaknesses: Post-mortem brains often belonged to medicated individuals, meaning receptor density changes could result from long-term drug use rather than schizophrenia itself. These studies also lack real-time data on dopamine activity.

  • Conclusion: While post-mortem studies provided early evidence for the dopamine hypothesis, their methodological limitations make modern imaging techniques more reliable.

BRAIN IMAGING: POSITIVE SYMPTOMS

  • Strengths: PET and fMRI studies have confirmed hyperdopaminergic activity in schizophrenia. Increased dopamine receptor density in the striatum correlates with psychotic symptoms.

  • Key Studies:

    • Lindström et al. (1999): Increased dopamine synthesis in the striatum of schizophrenic patients.

    • Howes et al. (2012): Elevated dopamine synthesis in individuals at high risk of schizophrenia, supporting dopamine's causal role.

    • Laruelle et al. (1996): Amphetamine challenge studies show greater dopamine release in schizophrenics than controls.

  • Weaknesses: Correlational nature—dopamine imbalances may be a consequence, not a cause, of schizophrenia.

  • Conclusion: Strong evidence links dopamine excess in the mesolimbic pathway to positive symptoms, but causation remains uncertain.

BRAIN IMAGING: NEGATIVE SYMPTOMS

  • Strengths: Negative symptoms correlate with dopamine hypoactivity in cortical areas, particularly:

    • Ventral striatum: Reduced activation linked to avolition.

    • Prefrontal cortex: Lower dopamine D1 receptor function associated with cognitive deficits.

  • Weaknesses: Imaging studies cannot establish causation—dopamine dysfunction could be a result rather than a cause.

  • Conclusion: Dopamine hypoactivity in cortical areas likely underlies negative symptoms, supporting a more nuanced dopamine hypothesis.

BEYOND DOPAMINE: GLUTAMATE & OTHER NEUROTRANSMITTERS

  • Glutamate's Role: Carlsson suggested dopamine imbalances may result from glutamate dysfunction. Glutamate regulates dopamine, and its disruption can cause both hyperdopaminergic (positive symptoms) and hypodopaminergic (negative symptoms) states.

  • Supporting Evidence: Clozapine, an effective antipsychotic for treatment-resistant schizophrenia, affects both dopamine and glutamate, suggesting multiple neurotransmitter involvement.

  • Conclusion: The dopamine hypothesis alone is insufficient—glutamate and serotonin likely play crucial roles in schizophrenia.

DOPAMINE AND OTHER PSYCHIATRIC DISORDERS

Dopamine imbalances are not unique to schizophrenia and are implicated in other psychiatric conditions, reinforcing the idea that dopamine dysfunction alone is insufficient to explain schizophrenia.

  • Bipolar Disorder (Mania): Elevated dopamine activity is associated with manic episodes, supporting the idea that dopamine dysregulation can lead to psychotic symptoms beyond schizophrenia.

  • Acute and Transient Psychotic Disorder: This disorder presents with brief episodes of psychosis linked to dopamine fluctuations, but unlike schizophrenia, it lacks persistent cognitive and negative symptoms.

  • Schizoaffective Disorder: This disorder has both schizophrenic and mood disorder symptoms, indicating dopamine dysfunction interacts with serotonin and glutamate imbalances.

  • Parkinson’s Disease and Dopamine Agonists: Parkinson’s is caused by dopamine deficiency in the substantia nigra. When treated with dopamine agonists (e.g., L-DOPA), some patients develop hallucinations and delusions, supporting the link between dopamine excess and psychotic symptoms.

CONCLUSION:

  • Dopamine imbalances contribute to multiple psychiatric conditions, demonstrating that dopamine dysfunction is not specific to schizophrenia.

  • The fact that schizophrenia shares dopamine abnormalities with other disorders suggests additional neural mechanisms must be involved, such as glutamate dysfunction, structural abnormalities, and prefrontal cortex deficits.

  • The dopamine hypothesis remains central to understanding schizophrenia, but must be considered alongside other neural correlates and neurotransmitter theories

GENETIC EXPLANATIONS OF SCHIZOPHRENIA ASSESSMENT

Family studies investigate people diagnosed with schizophrenia and examine whether their blood relatives are more likely to develop the condition compared to non-blood relatives.

Twins come in two forms: identical (monozygotic) and non-identical (fraternal or dizygotic). Identical twins develop when a single fertilised egg divides and forms two individuals who share identical genetic material.

Psychological theories, including genetic ones, are only as good as the research methods and the scientific understanding (zeitgeist) of their time. Early genetic explanations for schizophrenia relied on **family studies** and **twin concordance rates**, which provided initial evidence for heritability but suffered from serious methodological flaws, limiting their reliability and conclusions.

Early Evidence from Family and Twin Studies

Classic work by **Gottesman** (e.g., 1991 review of European twin studies from the 1920s–1980s) demonstrated that the risk of schizophrenia rises with genetic relatedness, pointing to a hereditary factor:

- **Monozygotic (MZ) twins** (100% genes shared): around 48% concordance rate

- **Dizygotic (DZ) twins** (50% genes shared): around 17% concordance rate

- **First-degree relatives** (e.g., siblings, parents, children): 9–13%

- **General population**: ~1%

The substantial gap between MZ and DZ concordance (often ~30%) was interpreted as strong evidence for genetic influence, as MZ twins are genetically identical while DZ twins share similar environments.

More recent estimates vary with diagnostic criteria and samples, but MZ concordance typically ranges from 33–65% (e.g., Danish twin register studies report ~33–44% probandwise for strict schizophrenia), with heritability estimates of around 73–81% from meta-analyses. DZ rates remain much lower (e.g., 3–10%).

Key Critiques of These Early Approaches

These studies faced major limitations that weaken claims of pure genetic causation:

No clear cause and effect** — Higher MZ concordance could stem from shared environment rather than genes alone. MZ twins are often treated more similarly (due to identical appearance, same gender, and closer bonding), resulting in more similar upbringings than DZ twins. Shared household, socioeconomic factors, and prenatal influences blur the line. Epigenetics further shows that even MZ twins differ in gene expression due to environmental exposures.

Temporal validity and diagnostic changes** — Many studies used outdated, broad definitions of schizophrenia (pre-DSM-III/DSM-5 eras), often including milder psychotic conditions or subtypes no longer recognised. Early criteria emphasised positive symptoms (e.g., hallucinations, delusions) but underplayed negative symptoms (e.g., social withdrawal, flat affect). Retrospective data couldn't be re-diagnosed with modern standards, reducing reliability and inflating concordance rates.

DZ twins vs ordinary siblings** — Despite sharing ~50% genes, DZ twins show higher concordance (~17%) than regular siblings (~9%). This suggests environmental/psychological factors: DZ twins are the same age, experience family events simultaneously, interpret parental behaviour at the same maturity level, and share the same family zeitgeist (dynamics, stresses, hierarchies). Age differences in siblings lead to different exposures and interpretations → nurture plays a bigger role than expected.

Separated MZ twin studies** — Gottesman and Shields (1982) reported ~58% concordance in a small sample (12 pairs reared apart), seeming to support genetics. However, samples were tiny (poor generalisability and statistical power), separations often traumatic (potentially contributing to risk), and some twins had contact or lived nearby (shared environment). Critics such as Jay Joseph (2003) argue that many "separated" cases weren't fully independent, thereby undermining claims.

Adoption Studies: Attempting Better Gene-Environment Separation

Adoption designs provide stronger evidence by separating genetic differences from the rearing environment.

Tienari's Finnish Adoption Study** (from 1969): Adopted children of schizophrenic biological mothers developed schizophrenia at ~7% (vs ~1.5% in controls from non-schizophrenic mothers), supporting genetic transmission.

But: Early-life issues (e.g., possible abuse/neglect before adoption, late separation from ill mothers) weren't fully controlled. Tienari found higher risk if adoptive families were dysfunctional → clear gene-environment interaction. Ethical concerns: Schizophrenic mothers likely couldn't consent to adoption or study participation.

- Similar results in Kety's Danish-American studies: Higher rates in biological relatives than adoptive ones.

Modern Understanding: Polygenic Risk and Specific Mechanisms

Schizophrenia is **polygenic** (many genes with small effects each), not monogenic. Genome-wide association studies (GWAS) have identified over 270 risk loci.

A key discovery is the **C4 gene** (Sekar et al., 2016; ongoing research through 2024–2025): variants increase C4A expression, leading to excessive synaptic pruning during adolescence (the brain removes excess synapses for efficiency). This results in reduced synaptic density and grey matter (especially in the prefrontal cortex), which explains cognitive deficits, the age of onset (late teens/early adulthood), and the neurodevelopmental nature (not neuron death).

Supporting evidence includes post-mortem studies, animal models (e.g., mice with altered C4 show over-pruning), cell cultures (microglia prune more in schizophrenia-linked cells), and biomarkers. Recent work (2024–2025) links C4 copy numbers to immune profiles, synaptic loss via AMPAR trafficking issues, and sex-specific effects (stronger in males).

However, C4 increases vulnerability, not certainty — many carriers never develop schizophrenia. It fits the **diathesis-stress model**: Genetic predisposition (e.g., C4 variants, other genes like DISC1, CACNA1C, GRIN2A) + environmental triggers (stress, trauma, cannabis use, urban living, migration, family dysfunction/high expressed emotion) → disorder emerges. Epigenetics shows that the environment alters gene expression without altering DNA.

C4 complements (doesn't replace) the dopamine hypothesis: Excessive pruning may disrupt cortical control over subcortical dopamine pathways.

RESEARCH

• Gottesman (1991) reported a 48% concordance rate for schizophrenia in identical (MZ) twins, compared to a 17% rate in fraternal (DZ) twins. This indicates that greater genetic similarity is associated with a higher risk of developing the disorder.

• Benzel et al. (2007) identified three genes—COMT, DRD4, and AKT1—that are connected to elevated dopamine levels at certain D2 receptors, which can trigger acute episodes and positive symptoms such as delusions, hallucinations, and unusual beliefs.

• Miyakawa et al. (2003) analysed DNA from families impacted by schizophrenia and discovered that affected individuals were more likely to carry a faulty form of the PPP3CC gene, which plays a role in producing calcineurin, a protein involved in regulating the immune system. Additionally, Sherrington et al. (1988) identified a gene on chromosome 5 that appeared linked to the disorder in a limited number of large families.

• Supporting evidence shows that the risk of schizophrenia increases with closer biological ties. Kendler (1985) demonstrated that first-degree relatives of people with schizophrenia face an 18 times greater risk than the general population. Gottesman (1991) also showed that the condition occurs more frequently among the biological family members of those affected, with risk increasing with the degree of genetic relatedness.

OVERALL EVALUATION

One limitation of the genetic explanation is the presence of methodological issues. Research involving families, twins, and adoptions needs careful interpretation because it is often retrospective, and diagnoses can be influenced by awareness that other relatives have already been identified as having the disorder. This raises concerns about potential bias or demand characteristics.

Another drawback relates to the nature-versus-nurture debate. Separating genetic influences from environmental ones is extremely challenging. Since concordance rates fall short of 100%, schizophrenia cannot be fully attributed to genetics alone; instead, individuals may inherit a vulnerability that increases their susceptibility when combined with certain environmental triggers. This means the biological approach does not provide a complete account of the condition.

A further weakness is that the genetic explanation can be seen as biologically reductionist. Advances from the Human Genome Project have highlighted the intricate nature of genes. With fewer genes identified than originally expected, it is now understood that individual genes can serve multiple functions and that behaviour is influenced by numerous genes that interact in complex ways.

Schizophrenia is regarded as a polygenic and multifactorial condition, arising from the combined effects of several genes and environmental influences. This complexity indicates that efforts to pinpoint specific genes oversimplify the disorder, as it is not caused by any single genetic factor.

Genetic explanations offer strong evidence of heritability (~70–80%) and reduce stigma by framing schizophrenia as biological/medical rather than moral or parental fault. Converging methods (twin/adoption/GWAS/C4) build a solid case.

But they are reductionist and deterministic — ignoring nurture overlooks that ~50% of MZ twins are discordant, showing environment's power. No full causal pathways yet; genes overlap other disorders (e.g., bipolar, autism); polygenic risk scores explain only ~25–30% of risk; limited direct treatments.

The best view is **interactionist**: Schizophrenia as a heterogeneous spectrum (DSM-5) arises from biology (genes, pruning, dopamine) interacting with psychology and environment. Genes may load the gun, but stress/environment pulls the trigger — no single cause, but a dynamic interplay.

It is crucial to recognise that genetic factors account for only part of the risk; if genes were the sole cause, identical twins would exhibit 100% concordance.

GENETIC QUESTIONS

SHORT QUESTIONS

  1. What is a concordance rate? (2 marks)

  2. What is meant by the term heritability in relation to schizophrenia? (2)

  3. What percentage of genes do monozygotic (MZ) twins share? (1)

  4. What is the general population risk of developing schizophrenia? (1)

  5. Give three other significant concordance rates for relatives of schizophrenics. (3 marks)

  6. What does it mean for the genetic explanation of schizophrenia to be polygenic? (2)

  7. Outline how twin studies are used to investigate the genetic basis of schizophrenia. (3)

  8. Describe one adoption study that provides evidence for the genetic explanation of schizophrenia. (3)

  9. What were the findings of the adoption study? (2 marks)

  10. Give four criticisms of family studies. (8 marks)

  11. Give two criticisms of twin studies. (4 marks)

  12. Give two criticisms of separated twin studies. (4 marks)

  13. Give two criticisms of adoption studies. (4 marks)

  14. Give two other criticisms of genetic explanations of schizophrenia. (4 marks)

  15. Explain the role of the C4 gene in schizophrenia. (4)

  16. Describe how genome-wide association studies (GWAS) have contributed to genetic research on schizophrenia. (4)

  17. Explain how molecular genetics has advanced the understanding of schizophrenia. (6)

  18. Why are these concordance rates important for the genetic argument? (5 marks)


APPLICATION AND ANALYSIS QUESTIONS (A02)

  1. A researcher finds that schizophrenia occurs more frequently in families where a close relative has already been diagnosed. Explain why this does not necessarily prove that schizophrenia is genetic. (3)

  2. A clinician observes that two identical twins raised apart have both developed schizophrenia, while another set of identical twins raised together has only one twin with schizophrenia. What could this suggest about the causes of schizophrenia? (4)

  3. A hospital records that patients with schizophrenia often have a biological parent with the disorder, but some do not. Using the diathesis-stress model, explain how this finding could be interpreted. (4)

  4. Researchers find that children born to parents with schizophrenia but adopted into non-schizophrenic families still show an increased risk of developing the disorder. Explain what this suggests about the nature-nurture debate in schizophrenia. (4)

  5. Explain why the diathesis-stress model provides a more comprehensive explanation of schizophrenia than purely genetic models. (6)

EVALUATION AND DISCUSSION QUESTIONS (A03)

  1. Explain two weaknesses of using twin studies to investigate schizophrenia. (4)

  2. Why might the difference in concordance rates between MZ and DZ twins not be purely genetic? (4)

  3. Why is the lack of a single schizophrenia gene a challenge for the genetic explanation? (4)

  4. Outline and evaluate family studies as evidence for the genetic explanation of schizophrenia. (6)

  5. Evaluate adoption studies as evidence for the role of genetics in schizophrenia. (6)

  6. Explain one strength and one limitation of genome-wide association studies (GWAS) in schizophrenia research. (6)

  7. Explain why the discovery of overlapping genetic risk factors for schizophrenia and bipolar disorder weakens the genetic explanation of schizophrenia. (6)

  8. Discuss the strengths and weaknesses of molecular genetic research into schizophrenia. (8)

  9. Compare and contrast the genetic explanation and the diathesis-stress model of schizophrenia. (8)

  10. Evaluate the strengths and limitations of twin studies as evidence for the genetic explanation of schizophrenia. (8)

EXTENDED RESPONSE QUESTIONS (A01/A02/A03)

  1. Evaluate family, twin, and adoption studies as evidence for the genetic explanation of schizophrenia. (10)

  2. Discuss the role of molecular genetics and genome-wide association studies in understanding schizophrenia. (10)

  3. Explain how the C4 gene’s role in synaptic pruning may provide a biological explanation for schizophrenia. (10)

  4. To what extent does research support the genetic explanation of schizophrenia? (12)

  5. Discuss the strengths and limitations of genetic explanations for schizophrenia, using research evidence. (16)

  6. Discuss one or more biological explanations for schizophrenia. (16 marks)

  7. Discuss biological explanations for schizophrenia. (16 marks)

  8. Describe and evaluate biological explanations for schizophrenia. Refer to the evidence in your answer. (16 marks)

  9. There is considerable evidence that biological factors cause schizophrenia. These can be genetic, neuroanatomical, biochemical, viral, or a combination of such factors.” Discuss biological explanations of schizophrenia. (16 marks).

  10. TASK: TURNING AO3 CRITIQUES INTO PEEL POINTS (SCHIZOPHRENIA – NATURE VS NURTURE)

    INSTRUCTIONS FOR STUDENTS

    You are given developed AO3 critiques. Your task is to restructure each critique into a PEEL paragraph. Follow the prompts carefully. Do not add new material. Do not generalise beyond what is stated.

    CRITIQUE 1: DIFFICULTY ESTABLISHING CAUSE AND EFFECT

    STEP 1 – POINT

    Identify the core methodological problem being raised.

    Sentence starter:

    One limitation of family and twin studies is that…

    STEP 2 – EVIDENCE

    Select the specific evidence that supports this limitation. Use only what is given.

    Prompt questions:

    • Which types of twins are compared?

    • What environmental factors do they share?

    Sentence starter:

    This is evident because MZ and DZ twins…

    STEP 3 – EXPLAIN

    Explain why this evidence weakens conclusions about genetics.

    Prompt questions:

    • Why do shared environments matter?

    • How might genetic vulnerability and environmental stress interact?

    Sentence starter:

    This makes it difficult to isolate genetic influences because…

    STEP 4 – LINK

    Link back to the wider debate about schizophrenia.

    Sentence starter:

    Therefore, these studies cannot conclusively show that…

    CRITIQUE 2: CHILDREN OF SCHIZOPHRENIC PARENTS

    STEP 1 – POINT

    Identify the assumption being challenged.

    Sentence starter:

    A limitation of interpreting concordance rates in children of schizophrenic parents is that…

    STEP 2 – EVIDENCE

    Use the named findings only.

    Prompt questions:

    • What concordance rates are cited?

    • What does adoption research suggest?

    Sentence starter:

    For example, Gottesman reported…, however Tienari found that…

    STEP 3 – EXPLAIN

    Explain how the family environment could independently increase risk.

    Prompt questions:

    • What aspects of schizophrenia affect parenting?

    • Why might this environment be stressful for a child?

    Sentence starter:

    Living with a schizophrenic parent may increase risk because…

    STEP 4 – LINK

    Link explicitly to the nature–nurture problem.

    Sentence starter:

    As a result, genetic and environmental influences…

    CRITIQUE 3: DZ TWINS VERSUS SIBLINGS

    STEP 1 – POINT

    State the comparative issue clearly.

    Sentence starter:

    Evidence from DZ twins and siblings suggests that…

    STEP 2 – EVIDENCE

    Use numerical data accurately.

    Prompt questions:

    • How genetically similar are DZ twins and siblings?

    • What are the respective concordance rates?

    Sentence starter:

    DZ twins share…, yet show a concordance rate of…, compared to…

    STEP 3 – EXPLAIN

    Explain why age and shared developmental context matter.

    Prompt questions:

    • How might siblings of different ages experience the same event differently?

    • Why does timing matter?

    Sentence starter:

    This difference may be explained by shared developmental experiences because…

    STEP 4 – LINK

    Link back to causation.

    Sentence starter:

    This challenges purely genetic explanations by suggesting that…

    EXTENSION (FOR STRONGER STUDENTS)

    • Underline where cause and effect is assumed rather than demonstrated

    • Identify one extraneous variable in each PEEL paragraph

    • Rewrite the POINT sentence so it could apply across multiple studies

ANSWERS

DIFFICULTY ESTABLISHING CAUSE AND EFFECT

Point: Family and twin studies struggle to establish a clear cause-and-effect relationship between genetics and schizophrenia.

Evidence: Although higher concordance rates in MZ twins than DZ twins are often taken as evidence for genetic influence, both types of twins share significant environmental factors, including the same household, socioeconomic conditions, and family culture.

Explain: These shared environments may account for similarities in concordance rates, making it difficult to isolate genetic effects. In addition, individuals with a genetic vulnerability to schizophrenia may also be more likely to experience environmental stressors such as family conflict or trauma, further blurring the distinction between nature and nurture.

Link: As a result, twin and family studies cannot conclusively demonstrate that genetics is the primary cause of schizophrenia, as environmental influences cannot be adequately controlled.

CHILDREN OF SCHIZOPHRENIC PARENTS

Point: Concordance rates in children of schizophrenic parents cannot be assumed to reflect purely genetic transmission.

Evidence: Gottesman reported concordance rates of 27 to 39 per cent for children with two schizophrenic parents, often interpreted as genetic. However, research by Tienari shows that many of these children are adopted away due to the severe impact of parental schizophrenia on child development.

Explain: Living with a schizophrenic parent is likely to be highly stressful and unpredictable, as the disorder can involve impaired cognition, language, and emotional regulation, as well as frightening delusions or hallucinations. This environment may disrupt emotional security and cognitive development, independently increasing the child’s risk of mental health problems.

Link: Therefore, genetic vulnerability and environmental stress are so closely intertwined that it is not possible to separate their individual contributions to the development of schizophrenia.

DZ TWINS VERSUS SIBLINGS

Point: Differences in concordance rates between DZ twins and non-twin siblings suggest environmental influences play a causal role.

Evidence: Dizygotic twins share approximately 50 per cent of their DNA, the same as ordinary siblings, yet DZ twins show higher concordance rates for schizophrenia (around 17 per cent) than siblings (around 9 per cent).

Explain: If schizophrenia were entirely genetic, these rates should be identical. The higher concordance in DZ twins may instead reflect shared environmental and psychological factors, such as exposure to family events at the same developmental stage and similar ways of interpreting family conflict. Siblings of different ages experience family dynamics differently as roles, stresses, and circumstances change over time.

Link: This pattern supports the view that environmental and developmental factors contribute to schizophrenia risk, challenging purely genetic explanations.

PEELED POINTS ADOPTION STUDIES

ADOPTION STUDIES – SUPPORT FOR A GENETIC EXPLANATION

Point: Adoption studies provide strong evidence for a genetic contribution to schizophrenia by separating biological inheritance from the rearing environment.

Evidence: Adoption research shows that children adopted from schizophrenic mothers have a 7 per cent risk of developing schizophrenia, compared with 1.5 per cent for adoptees from non schizophrenic mothers, despite being raised in different families. Tienari’s study was a prospective longitudinal natural experiment that avoided many problems associated with retrospective family and twin studies. Similar findings were reported by Kety and Heston, increasing the reliability of the results.

Explain: Because the children were raised away from their biological parents, environmental explanations linked to direct parental influence are reduced, strengthening the argument that genetic factors increase vulnerability to schizophrenia. The prospective design also avoids recall bias and allows clearer observation of outcomes over time.

Link: This suggests that genetics plays a significant role in schizophrenia risk, although this does not imply genetic determinism.

ISSUES WITH INTERNAL VALIDITY IN ADOPTION STUDIES

Point: Despite their strengths, adoption studies suffer from internal validity issues that weaken genetic conclusions.

Evidence: Although Tienari claimed to match experimental and control groups, schizophrenic adoptees were removed from their mothers before age four and adopted between ages five and seven, with no clear account of where they lived during the intervening period. It is also unknown whether these children experienced deprivation, privation, or abuse, whereas control adoptees did not experience similar late adoption or early disruption.

Explain: Early trauma, neglect, or institutional care are known to have long-term effects on emotional regulation, language development, and relationships, as demonstrated by research on early deprivation. These uncontrolled early environmental factors may independently increase vulnerability to schizophrenia, making it impossible to attribute outcomes solely to genetics.

Link: Therefore, adoption studies cannot conclusively demonstrate that increased schizophrenia risk is purely genetic, as critical extraneous variables were not adequately controlled.

INTERACTION BETWEEN GENETIC VULNERABILITY AND ENVIRONMENT

Point: Adoption studies themselves support an interactionist explanation of schizophrenia rather than a purely genetic one.

Evidence: Tienari found that adoptees were more likely to develop schizophrenia if they were raised in disturbed adoptive families.

Explain: This indicates that genetic vulnerability alone is insufficient and that environmental stressors play a key role in triggering the disorder. A supportive environment may reduce risk, whereas a disturbed family context may activate underlying vulnerability.

Link: This supports the diathesis stress model, which proposes that schizophrenia results from an interaction between biological predisposition and environmental stress.

ETHICAL ISSUES IN TIENARI’S STUDY

Point: Tienari’s adoption research raises significant ethical concerns.

Evidence: Many of the children studied were likely taken from their biological mothers without informed consent. If the mothers were schizophrenic, they may have lacked the capacity to consent during active phases of illness.

Explain: Studying children who may have been removed under ethically questionable circumstances raises concerns about benefitting from decisions made without valid consent, particularly when mental incapacity is involved.

Link: These ethical issues complicate the interpretation of the findings and highlight the moral limitations of using adoption studies to investigate schizophrenia.

LIMITATIONS OF DIAGNOSTIC VALIDITY IN GENETIC RESEARCH

Point: Family, twin, and adoption studies investigating the genetics of schizophrenia are limited by problems with diagnostic validity.

Evidence: Many early studies relied on broad and inconsistent diagnostic criteria that predate the introduction of DSM-III in 1980 and subsequent refinements in DSM-5. These earlier classifications included subtypes and milder psychotic disorders that are no longer recognised within modern diagnostic frameworks.

Explain: As a result, individuals who would not meet current diagnostic thresholds for schizophrenia may have been included in research samples. This weakens construct validity and makes it difficult to determine whether findings genuinely relate to schizophrenia as currently defined.

Link: Therefore, conclusions drawn from early genetic studies must be treated with caution, as they may not accurately reflect the disorder recognised today.

IMPACT ON CONCORDANCE AND HERITABILITY ESTIMATES

Point: Outdated diagnostic criteria may have inflated concordance rates reported in genetic studies of schizophrenia.

Evidence: Studies analysed by Gottesman, as well as adoption research such as Tienari’s and Kety’s Danish American study, were conducted during periods when diagnostic standards varied considerably. Diagnoses often included conditions such as paranoid schizophrenia or other psychotic disorders that are no longer classified separately or at all.

Explain: Including a wider range of disorders increases the likelihood that twins or biological relatives will appear concordant, artificially raising estimates of heritability in both twin and adoption studies.

Link: This suggests that reported genetic influence in early research may be overstated due to inconsistent diagnostic boundaries.

IMPLICATIONS FOR MODERN RESEARCH

Point: Early genetic findings must be reinterpreted in light of modern diagnostic standards.

Evidence: While meta-analyses, twin studies, and adoption studies consistently suggest a genetic component to schizophrenia, many were based on classifications that lack consistency with current DSM criteria.

Explain: Without applying contemporary diagnostic definitions, it is not possible to accurately quantify the genetic contribution to schizophrenia. Modern research requires stricter classification to distinguish schizophrenia from related but distinct psychotic conditions.

Link: Consequently, although early research supports a genetic role, its findings should be contextualised rather than taken as precise estimates of heritability.

C4 GENE PEELED

STRENGTHS OF THE C4 EVIDENCE BASE

Point: A major strength of the C4 explanation is the breadth and convergence of supporting evidence.

Evidence: Support for the C4 gene comes from genome-wide association studies, post-mortem brain analysis, animal experiments, cell culture research, biomarker studies, and brain imaging.

Explain: This triangulation across multiple methods increases confidence that the findings are robust and not artefacts of a single research approach. Unlike earlier genetic studies, the C4 explanation also provides a clear biological mechanism by showing how gene expression can influence synaptic pruning during brain development.

Link: As a result, the C4 explanation represents a more sophisticated and biologically grounded account of schizophrenia risk than earlier genetic associations without mechanisms.

EXPLANATORY POWER OF THE C4 THEORY

Point: The C4 explanation has high explanatory power for key features of schizophrenia.

Evidence: Excessive synaptic pruning linked to C4A expression explains reduced grey matter and synaptic density, the absence of neuron loss, and the typical onset of schizophrenia in late adolescence when pruning peaks.

Explain: This developmental account goes beyond adult neurotransmitter imbalance by explaining how structural brain changes emerge over time rather than appearing suddenly in adulthood.

Link: This strengthens the C4 explanation compared with accounts that focus solely on dopamine dysfunction without addressing developmental changes.

LIMITATIONS OF THE C4 EXPLANATION

Point: Despite strong evidence, the C4 explanation is not deterministic and has limited predictive value.

Evidence: Many individuals with high C4A expression do not develop schizophrenia, indicating that the gene increases vulnerability rather than directly causing the disorder.

Explain: This means genetic risk alone is insufficient and must interact with other factors for schizophrenia to develop.

Link: Therefore, C4 cannot be treated as a single causal explanation for schizophrenia.

METHODOLOGICAL AND REDUCTIONIST LIMITATIONS

Point: The evidence base for C4 relies heavily on non-human models and risks biological reductionism.

Evidence: Much of the mechanistic research uses animal models and laboratory systems such as mice and cell cultures.

Explain: While these methods allow experimental control, they may not fully represent the complexity of the human brain or the higher cognitive and social processes involved in schizophrenia. Focusing on synaptic pruning alone may also underplay established environmental risk factors such as childhood trauma, prenatal stress, social adversity, and cannabis use.

Link: This limits the extent to which the C4 explanation can account for schizophrenia in isolation.

RELATIONSHIP TO OTHER EXPLANATIONS

Point: The C4 explanation complements rather than replaces existing biological theories.

Evidence: Excessive pruning may disrupt cortical regulation of subcortical dopamine systems, helping to explain dopamine dysregulation observed in schizophrenia.

Explain: This supports an interactionist framework in which developmental brain changes and neurotransmitter abnormalities are linked rather than competing explanations.

Link: The C4 explanation, therefore, fits well alongside the dopamine hypothesis rather than contradicting it.

DIATHESIS STRESS MODEL

Point: The C4 explanation aligns closely with the diathesis stress model of schizophrenia.

Evidence: C4A expression represents a genetic vulnerability that only leads to schizophrenia when combined with environmental stressors.

Explain: This explains why not all individuals with genetic risk develop the disorder and highlights the role of environmental triggers.

Link: This supports the view that schizophrenia results from interactions between biological and environmental factors.

PRACTICAL AND ETHICAL CONSIDERATIONS

Point: At present, C4 research has limited direct clinical application.

Evidence: There is no safe or ethical method for altering synaptic pruning during development.

Explain: Intervening in early brain development carries significant ethical risks, which limit the immediate treatment implications. However, the findings may aid early identification of risk and encourage preventative approaches.

Link: This suggests the value of C4 research lies more in early intervention and prevention than direct treatment.

OVERALL CONCLUSION

Point: Overall, C4 research represents a major advance in biological explanations of schizophrenia.

Evidence: It provides a coherent developmental account supported by converging evidence across multiple research methods.

Explain: However, it explains increased risk rather than certainty and cannot account for schizophrenia without reference to environmental and psychological factors.

Link: Therefore, the C4 explanation is best understood as part of an interactionist framework rather than a standalone cause.

ESSAY EXEMPLARS

3-MARK A01 RESPONSE

Schizophrenia is believed to have a genetic basis, as studies show the risk increases with genetic similarity. Twin studies show that monozygotic (MZ) twins have a 48% concordance rate, while dizygotic (DZ) twins have only a 17% concordance rate, suggesting a strong genetic component. Adoption studies, such as Tienari’s Finnish Adoption Study, further support this, as children of schizophrenic biological parents were more likely to develop schizophrenia, even when raised in non-schizophrenic adoptive families.

Recent genetic research has identified specific genes, such as the C4 gene, linked to excessive synaptic pruning in the adolescent brain. This may contribute to the development of schizophrenia by affecting neural pathways involved in cognition and perception. However, schizophrenia is now understood to be polygenic, meaning multiple genes contribute to its growth rather than a single identifiable cause.

6-MARK A01 RESPONSE

The genetic explanation of schizophrenia suggests that the disorder is inherited, with research providing strong evidence for a genetic component. Twin studies have demonstrated that schizophrenia is more likely to occur in individuals with a higher degree of genetic relatedness. Gottesman and Shields (1991) found that monozygotic (MZ) twins have a 48% concordance rate, meaning if one twin has schizophrenia, there is a 48% chance the other will develop it. In contrast, dizygotic (DZ) twins have a significantly lower concordance rate of 17% despite sharing the same environment. This suggests that genetics plays a key role in the disorder. Family studies also show that schizophrenia runs in families: the risk for first-degree relatives (parents, siblings, children) is 9-13%, while for second-degree relatives (e.g., half-siblings, uncles, aunts) it is 2-6%, and for third-degree relatives (e.g., cousins) it is around 2%. The general population risk remains at 1%, supporting a genetic influence.

Adoption studies further support the genetic explanation by showing that schizophrenia risk remains even when individuals are raised in different environments. Tienari’s Finnish Adoption Study found that 7% of adoptees with schizophrenic biological mothers developed schizophrenia, compared to 1.5% in the control group, suggesting that biological inheritance plays a role. However, as not all genetically at-risk individuals develop schizophrenia, researchers have turned to specific genetic factors to understand its causes.

Recent genetic research has identified specific genes linked to schizophrenia. One of the most significant discoveries is the C4 gene, which regulates synaptic pruning—a process that removes excess neural connections during adolescence. Sekar et al. (2016) found that overactive C4 function leads to excessive synaptic loss, particularly in the prefrontal cortex, an area responsible for cognition, memory, and decision-making. This may explain why individuals with schizophrenia experience disorganised thinking and cognitive deficits.

Schizophrenia is now understood to be polygenic, meaning multiple genes contribute to its development rather than a single gene being responsible. Other genes, such as DISC1, CACNA1C, and GRIN2A, have been linked to schizophrenia, further supporting the idea that genetic and neurobiological factors interact in the development of the disorder.

10-MARK A03 EVALUATION RESPONSE (APPROX. 600 WORDS, PEC STRUCTURE)

POINT 1: FAMILY STUDIES PROVIDE EVIDENCE FOR A GENETIC LINK, BUT ENVIRONMENTAL FACTORS CANNOT BE RULED OUT

  • EXPLAIN: Family studies show that schizophrenia runs in families, suggesting a genetic basis. Gottesman and Shields (1991) found that first-degree relatives (parents, siblings, children) have a 9-13% risk, compared to 2-6% for second-degree relatives and 1% in the general population. This pattern of risk supports the idea that schizophrenia has a heritable component.

  • CRITIQUE: However, family studies fail to separate genetic influence from shared environmental factors. Families not only pass on genes but also provide shared experiences that may contribute to schizophrenia. Expressed emotion (EE), a pattern of high criticism, hostility, and emotional over-involvement, has been linked to schizophrenia relapse, showing that environment plays a role.

  • CONSEQUENCE: This suggests that family studies alone are not sufficient evidence for a purely genetic explanation, as they cannot disentangle whether schizophrenia is inherited biologically or learned through dysfunctional family dynamics.

POINT 2: TWIN STUDIES PROVIDE STRONGER GENETIC EVIDENCE, BUT ENVIRONMENT STILL MATTERS

  • EXPLAIN: Twin studies strengthen the genetic argument by comparing monozygotic (MZ) twins, who share 100% of their DNA, with dizygotic (DZ) twins, who share 50%. Gottesman and Shields (1991) found that MZ twins have a 48% concordance rate, whereas DZ twins have a 17% concordance rate, suggesting a strong genetic component.

  • CRITIQUE: However, if schizophrenia were purely genetic, the MZ concordance rate should be 100%, yet over half of genetically identical twins remain unaffected. This suggests that environmental factors must also contribute. Additionally, MZ twins often experience more similar environments (e.g., being treated alike by parents, sharing the same social experiences), which could inflate genetic estimates.

  • CONSEQUENCE: While twin studies support a genetic predisposition to schizophrenia, they also show that genes alone are not enough to trigger the disorder, supporting the diathesis-stress model, where genetic vulnerability interacts with environmental stressors.

POINT 3: ADOPTION STUDIES PROVIDE STRONGER EVIDENCE FOR GENETICS BUT HAVE METHODOLOGICAL ISSUES

  • EXPLAIN: Adoption studies help to separate genetic and environmental influences. Tienari’s Finnish Adoption Study found that 7% of adoptees with schizophrenic biological mothers developed schizophrenia, compared to 1.5% in control adoptees with no family history. This suggests that schizophrenia risk remains even when children are raised in non-schizophrenic households, supporting the genetic hypothesis.

  • CRITIQUE: However, adoption studies are not perfect. Many adoptees do not experience completely different environments, as adoption agencies often place children in homes that match their biological background (selective placement bias). Additionally, adopted children may have experienced trauma or neglect before adoption, which could independently increase their risk of schizophrenia.

  • CONSEQUENCE: Although adoption studies provide more substantial support for genetic factors than family studies, they cannot fully control for early environmental influences, meaning schizophrenia cannot be explained purely in terms of genetics.

POINT 4: MOLECULAR GENETICS HAS IDENTIFIED RISK GENES, BUT NO SINGLE "SCHIZOPHRENIA GENE" EXISTS

  • EXPLAIN: Recent genome-wide association studies (GWAS) have identified specific genes associated with schizophrenia. The C4 gene, which regulates synaptic pruning, has been associated with excessive neural loss in the prefrontal cortex, potentially explaining cognitive and thought disturbances in schizophrenia (Sekar et al., 2016). Other genes, such as DISC1, CACNA1C, and GRIN2A, have also been linked to dopamine regulation and brain development, supporting the idea that schizophrenia has a biological basis.

  • CRITIQUE: However, schizophrenia is now recognised as polygenic, meaning multiple genes contribute, and no single gene determines whether someone will develop the disorder. Additionally, many genes linked to schizophrenia, such as CACNA1C, are also associated with bipolar disorder and depression, raising questions about whether schizophrenia is a distinct genetic disorder or part of a broader psychiatric spectrum.

  • CONSEQUENCE: While molecular genetics has provided biological insights, genetic findings lack predictive power—having schizophrenia-related genes does not mean someone will develop the disorder. This suggests that environmental factors must interact with genetic risk, further supporting the diathesis-stress model.

POINT 5: THE DIATHESIS-STRESS MODEL PROVIDES A MORE BALANCED EXPLANATION

  • EXPLAIN: The diathesis-stress model suggests that schizophrenia develops due to a combination of genetic vulnerability (diathesis) and environmental stressors (stress). Evidence shows that schizophrenia risk increases with exposure to stressors such as childhood trauma, cannabis use, urban living, and social isolation.

  • CRITIQUE: This model explains why some individuals with genetic risk never develop schizophrenia, as they may not encounter the necessary environmental triggers. It also accounts for why identical twins do not always both develop schizophrenia, despite sharing the same genes.

  • CONSEQUENCE: The diathesis-stress model is more comprehensive than purely genetic explanations, as it integrates biological and environmental factors, making it a superior explanation of schizophrenia

16-MARK A01 RESPONSE

Jay has schizophrenia. His speech is rapid and confusing, constantly shifting from one idea to another. Jay’s father was treated for mental health problems when he was younger. Jay’s mother worries excessively about Jay. She often criticises his behaviour and tells him what to do. Jay’s doctor prescribes medication, which seems to reduce his symptoms.

Discuss one or more explanations for schizophrenia. Refer to Jay in your answer. (16 marks)

AO1 (6 marks)

One explanation for schizophrenia is the dopamine hypothesis. The original dopamine hypothesis proposes that positive symptoms—such as hallucinations, delusions, and disorganised thinking—arise from excess dopamine in the mesolimbic pathway, where overstimulation of D2 receptors distorts the brain’s salience system. This makes irrelevant stimuli feel meaningful.

However, the reformulated dopamine hypothesis argues that schizophrenia involves two opposite dopamine abnormalities:
• Hyperdopaminergia in the mesolimbic pathway → positive symptoms
• Hypodopaminergia in the mesocortical pathway → negative and cognitive symptoms due to reduced D1 receptor activity in the prefrontal cortex

A second biological explanation is genetic vulnerability. Schizophrenia is highly heritable, and having a first-degree relative with the disorder increases risk. Genes may influence dopamine regulation or early neurodevelopment.

AO2 (4 marks) – APPLYING TO JAY

Jay’s rapid, confusing speech and constant derailment reflect mesolimbic dopamine hyperactivity, which disrupts coherent thinking. His improvement after medication supports the dopamine hypothesis because antipsychotics reduce dopamine transmission.

Jay’s father, having been treated for mental health problems, suggests a genetic predisposition, fitting the genetic explanation. Jay’s mother’s excessive worry and criticism reflect high expressed emotion, an environmental stressor known to trigger relapse in genetically vulnerable individuals. This shows how biological vulnerability and stress interact to produce Jay’s symptoms.

AO3 (6 marks)

A significant strength of the dopamine hypothesis is drug evidence: antipsychotics that block D2 receptors reduce positive symptoms, while dopamine agonists (e.g., L-DOPA) can induce psychosis. Brain-imaging research (e.g., Howes et al.) also shows elevated dopamine synthesis in high-risk groups.

However, dopamine findings are correlational, meaning dopamine abnormalities may be a result of schizophrenia, not a cause. Around one-third of patients show little dopamine abnormality yet remain symptomatic, limiting the explanatory power of dopamine alone. The hypothesis also struggles to fully explain negative symptoms.

Genetic theories are supported by family, twin, and adoption studies showing higher concordance in genetically related individuals. Yet identical twins show only ~48% concordance, proving that genetics alone is insufficient. Environmental factors—such as the family stress Jay experiences—must interact with biological vulnerability, supporting a diathesis–stress model rather than a single cause.

CONCLUSION

Jay’s symptoms are well accounted for by biological explanations: mesolimbic dopamine hyperactivity explains his disorganised thoughts, and genetic vulnerability explains his family history. However, the role of High Expressed emotion in his home shows that schizophrenia is best explained by an interaction between biological risk and environmental stress, not biology alone.

PSYCHOLOGICAL EXPLANATIONS OF SCHIZOPHRENIA QUESTIONS

COGNITIVE EXPLANATIONS ASSESSMENT

  1. What is a dysfunctional thought process? (4 marks)

  2. What is a cognitive explanation of schizophrenia? (6 marks)

  3. Give two disadvantages of the cognitive explanation for schizophrenia. (4 marks)

  4. Give two advantages of the cognitive explanation for schizophrenia. (4 marks)

DOUBLE-BIND THEORY (BATESON) ASSESSMENT

  1. What terms are used by family systems theorists to describe A and B below? (2 marks)

    Being free to decide how to behave and feel in control of one’s life.

    When a family is overprotective, distinctions between family members are blurred.

  2. Briefly outline family dysfunction as an explanation for schizophrenia. (2 marks).

  3. What is a double bind? (3 marks).

  4. How do researchers measure double binds? (4 marks).

  5. Name and outline two studies that support the double bind theory. (4 marks).

  6. Outline one psychological explanation of schizophrenia. (4 marks),

  7. Briefly discuss two limitations of the family dysfunction explanation for schizophrenia. (4 marks)

  8. What is a family's dysfunctional explanation of schizophrenia? (6 marks)

  9. According to Bateson, schizophrenia is caused by double binds; explain how. (6 marks).

  10. Evaluate one psychological explanation for schizophrenia. (6 marks).

  11. Explain how family dysfunction might be involved in schizophrenia. Refer to one or more types of family dysfunction in your answer. (6 marks).

  12. Why do psychological explanations of schizophrenia, such as the double bind theory, struggle to obtain scientifically valid and reliable studies to support their theories? (8 marks).

  13. Jack has been diagnosed with schizophrenia. He describes his family background to his therapist:
    "I could never talk to Mum. She fussed over me all the time. I tried to do what she said, but could never please her. One minute, she seemed all affectionate, and the next minute, she would make nasty comments. My dad hated all the arguments and stayed out of it."
    Describe the family dysfunction explanation for schizophrenia, and explain how Jack’s experiences can be linked to the family dysfunction explanation. (8 marks)

  14. Evaluate psychological explanations of schizophrenia. (16 marks)

  15. Outline and evaluate one or more psychological explanations for schizophrenia. (16 marks)

EXPLANATIONS FOR SCHIZOPHRENIA: EXPRESSED EMOTION (EE) ASSESSMENT

  1. What is expressed emotion (EE), e.g., what is high expressed emotion (HEE)? (4 marks)

  2. What is low-expressed emotion (LEE)? (4 marks)

  3. How do researchers measure EE? (4 marks)

  4. Name and outline two studies that support the expressed emotion theory. (6 marks)

  5. Expressed emotion theory does not explain the cause of schizophrenia, only the course of the illness. Explain what that means, e.g., what is the difference between course and cause explanations of schizophrenia? (8 marks)

  6. Why is it easier to research psychological explanations, such as EE theory, that investigate the course of the illness? (6 marks)

  7. How does EE affect the course of schizophrenia? (4 marks)

  8. What other evaluative points about EE theory should be considered? (4 marks)

INTERACTIONIST MODEL ASSESSMENT

  1. What is the interactionist theory of schizophrenia? (4 marks)

  2. What is the diathesis-stress model of schizophrenia? (4 marks)

  3. What support does the interactionist model have that shows schizophrenia is caused by both nature and nurture? (6 marks)

DRUG TREATMENT FOR SCHIZOPHRENIA ASSESSMENT

  1. Outline the function of dopamine, e.g., what does it do? (4 marks)

  2. Describe problems people may experience with imbalances in dopamine production, e.g., excess and deficiency. (4 marks)

  3. What is an agonist? (2 marks)

  4. What is an antagonist? (2 marks)

  5. What is an antipsychotic? (2 marks)

  6. What is a typical or conventional antipsychotic? (2 marks)

  7. How did antipsychotics originate? (2 marks)

  8. Name two typical antipsychotics. (2 marks)

  9. How do typical antipsychotics work? (2 marks)

  10. What are the four adverse symptoms of taking typical antipsychotics? (2 marks)

  11. Name two other issues that devalue the efficacy of typical antipsychotics. (2 marks)

  12. What is an Atypical antipsychotic? (2 marks)

  13. Name two Atypical antipsychotics. (2 marks)

  14. Give two advantages of taking Atypical antipsychotics versus taking typical antipsychotics. (4 marks)

  15. Name two disadvantages of taking Atypical antipsychotics. (4 marks)

  16. What are the findings regarding the length of time on typical and Atypical antipsychotics? (4 marks)

PSYCHOLOGICAL TREATMENTS FOR SCHIZOPHRENIA ASSESSMENT

TOKEN ECONOMIC TREATMENTS FOR SCHIZOPHRENIA QUESTIONS

  1. What is a token economy? (3 marks)

  2. How is it theorised that a token economy helps schizophrenia patients? (3 marks)

  3. What form of behaviourism is the token economy derived from? Give an example. (3 marks)

  4. Give three disadvantages of using a token economy. (6 marks)

COGNITIVE BEHAVIOURAL THERAPY TREATMENTS FOR SCHIZOPHRENIA ASSESSMENT

  1. What is cognitive behavioural therapy (CBT), and how is it used to treat schizophrenia? (4 marks)

  2. Name two key techniques used in CBT for schizophrenia. (4 marks)

  3. Explain one advantage and one disadvantage of using CBT to treat schizophrenia. (4 marks)

  4. Why might CBT not be effective for all schizophrenia patients? (4 marks)

RELIABILITY AND VALIDITY OF SCHIZOPHRENIA ASSESSMENT

  1. What does reliability mean in the context of diagnosing schizophrenia? (3 marks)

  2. What does validity mean in the context of diagnosing schizophrenia? (3 marks)

  3. Explain how co-morbidity affects the validity of the schizophrenia diagnosis. (4 marks)

  4. Explain how symptom overlap affects the reliability of schizophrenia diagnosis. (4 marks)

  5. Discuss how cultural bias can impact the diagnosis of schizophrenia. (6 marks)

  6. Discuss how gender bias can impact the diagnosis of schizophrenia. (6 marks)

  7. Describe one study that investigates the reliability of schizophrenia diagnosis. (4 marks)

  8. Describe one study that investigates the validity of schizophrenia diagnosis. (4 marks)

  9. Discuss issues associated with reliability and validity in diagnosing and classifying schizophrenia. (16 marks)

AQA SCHIZOPHRENIA EXAM QUESTIONS

FAMILY SYSTEMS AND PSYCHOLOGICAL EXPLANATIONS

NEURAL CORRELATES AND SCHIZOPHRENIA

  1. Which of the following best describes neural correlates as an explanation for schizophrenia? Shade one box only. (1 mark)

  • A: There is a correlation between brain plasticity and symptoms of schizophrenia.

  • B: There is a correlation between brain structure and function and symptoms of schizophrenia.

  • C: There is a correlation between dysfunctional thinking and symptoms of schizophrenia.

INTERACTIONIST APPROACH

  1. Discuss the use of an interactionist approach in explaining and treating schizophrenia. (16 marks)

  2. Outline one or more biological explanations for schizophrenia. Compare biological explanation(s) for schizophrenia with the family dysfunction explanation for schizophrenia. (16 marks)

ANTIPSYCHOTIC DRUGS

  1. Outline and evaluate the use of antipsychotic drugs to treat schizophrenia. (8 marks)

  2. Apart from effectiveness, briefly explain one limitation of drug therapy for schizophrenia. (2 marks)

  3. Read the item and then answer the questions that follow:
    Two years ago, Jenny was diagnosed with schizophrenia. She has been taking an atypical antipsychotic drug, and there have been improvements in her positive symptoms. However, she still suffers negative symptoms and side effects. Her psychiatrist wants to change her medication from typical antipsychotics to one of the atypical antipsychotics and has also suggested cognitive behavioural therapy.

  • A. Outline one negative symptom of schizophrenia. (2 marks)

  • B. Concerning the item above, explain why Jenny’s psychiatrist wants to move her on to one of the atypical antipsychotics. (4 marks)

  • C. Briefly explain one advantage of cognitive behavioural therapy in treating schizophrenia. (2 marks)

TOKEN ECONOMIES

  1. Below are four evaluative statements about token economies used in the treatment of schizophrenia. Which statement is TRUE? Shade one box only. (1 mark)

  • A: Token economies can be used effectively in any environment.

  • B: Token economies have a positive effect on thinking.

  • C: Token economies help to promote acceptable behaviours.

  • D: Token economies address the cause of the problem.

  1. Discuss token economies as a method for managing schizophrenia. (8 marks)

COGNITIVE BEHAVIOURAL THERAPY (CBT)

  1. Briefly outline how cognitive behavioural therapy (CBT) is used to treat schizophrenia and explain one limitation of using CBT to treat schizophrenia. (4 marks)

  2. Jay and Mary are clinical psychologists. They each work with patients who have schizophrenia. Both Jay and Mary treat their patients without the use of drugs. Jay explains that he involves close relatives in treatment to reduce tension. Mary describes how she helps patients understand their thoughts and develop effective strategies to help themselves.
    Describe and evaluate family therapy and cognitive behavioural therapy as treatments for schizophrenia. Refer to Jay and Mary in your answer. (16 marks)

  3. Martine has schizophrenia. She is afraid because she believes that her care workers are trying to hurt her. She hears voices telling her to lock the doors and windows so the care workers cannot enter her house. She thinks about nothing else. Explain how a cognitive behaviour therapist might treat Martine’s symptoms. (4 marks)

  4. "Therapies can be time-consuming and, in some cases, uncomfortable for the client. Therefore, it is essential to offer the most appropriate and effective treatment."
    Outline and evaluate two or more therapies used in the treatment of schizophrenia. (16 marks)

  5. Outline and compare two treatments for schizophrenia. (16 marks)

RELIABILITY AND VALIDITY IN SCHIZOPHRENIA DIAGNOSIS

  1. What terms are used by psychologists to describe A and B below? (2 marks)

  • A When a person has two or more disorders at the same time.

  • B When two different disorders have a symptom in common.

  1. Briefly outline and evaluate one study on the validity of the diagnosis of schizophrenia. (4 marks)

  2. Discuss issues associated with reliability and validity in the diagnosis and classification of schizophrenia, including reference to co-morbidity, culture and gender bias, and symptom overlap. (16 marks)




Rebecca Sylvia

I am a Londoner with over 30 years of experience teaching psychology at A-Level, IB, and undergraduate levels. Throughout my career, I’ve taught in more than 40 establishments across the UK and internationally, including Spain, Lithuania, and Cyprus. My teaching has been consistently recognised for its high success rates, and I’ve also worked as a consultant in education, supporting institutions in delivering exceptional psychology programmes.

I’ve written various psychology materials and articles, focusing on making complex concepts accessible to students and educators. In addition to teaching, I’ve published peer-reviewed research in the field of eating disorders.

My career began after earning a degree in Psychology and a master’s in Cognitive Neuroscience. Over the years, I’ve combined my academic foundation with hands-on teaching and leadership roles, including serving as Head of Social Sciences.

Outside of my professional life, I have two children and enjoy a variety of interests, including skiing, hiking, playing backgammon, and podcasting. These pursuits keep me curious, active, and grounded—qualities I bring into my teaching and consultancy work. My personal and professional goals include inspiring curiosity about human behaviour, supporting educators, and helping students achieve their full potential.

https://psychstory.co.uk
Previous

TOKEN ECONOMIES FOR SCHIZOPHRENIA

Next

THE RELIABILITY AND CLASSIFICATION OF SCHIZOPHRENIA